Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

NCT05908682 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-07-17

No results posted yet for this study

Summary

This is an ongoing evaluation of subjects exposed to ibrexafungerp while pregnant. The study population will include pregnant women of any age.

Conditions

  • Vulvovaginal Candidiasis
  • Candida Infection
  • Vaginal Candidiasis

Interventions

OTHER

Non-interventional study

This is not an interventional study

Sponsors & Collaborators

  • AWINSA

    collaborator UNKNOWN
  • Scynexis, Inc.

    lead INDUSTRY

Eligibility

Min Age
0 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-28
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05908682 on ClinicalTrials.gov